N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases

被引:0
作者
Arumugam Paramasivam
Jayaseelan Vijayashree Priyadharsini
Subramanian Raghunandhakumar
机构
[1] Saveetha University,BRULAC
[2] Anna University,DRC, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS)
来源
Hypertension Research | 2020年 / 43卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:153 / 154
页数:1
相关论文
共 50 条
  • [21] Role of m6A methylation in retinal diseases
    Zhu, Xinyu
    Zhou, Chuandi
    Zhao, Shuzhi
    Zheng, Zhi
    EXPERIMENTAL EYE RESEARCH, 2023, 231
  • [22] Regulation of mRNA N6-adenosine methylation by the mTOR signaling.
    Lee, Gina
    Cho, Sungyun
    Pickering, Brian F.
    Jang, Cholsoon
    Rabinowitz, Joshua D.
    Jaffrey, Samie R.
    Blenis, John
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 34 - 34
  • [23] Deregulation of RNA N6-adenosine methylation contribute to liver carcinogenesis
    Chen, Mengnuo
    Wei, Larry L.
    Law, Cheuk Ting
    Tsang, Felice H. C.
    Xu, Iris M. J.
    Lee, Joyce M. F. Lee
    Wong, Carmen C. L. Wong
    Ng, Irene O. L.
    Wong, Chun-Ming
    CANCER RESEARCH, 2017, 77
  • [24] Interplay between N6-adenosine RNA methylation and mRNA splicing
    Mehravar, Majid
    Wong, Justin J-L
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2024, 87
  • [25] WTAP–VIRMA counteracts dsDNA binding of the m6A writer METTL3–METTL14 complex and maintains N6-adenosine methylation activity
    Xuhui Yan
    Feiqing Liu
    Junjun Yan
    Mengjun Hou
    Min Sun
    Delin Zhang
    Zhou Gong
    Xu Dong
    Chun Tang
    Ping Yin
    Cell Discovery, 9
  • [26] M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics
    Yurong Huang
    Qiuyun Xue
    Jun Chang
    Yuting Wang
    Chenglong Cheng
    Suowen Xu
    Xiao Wang
    Chenggui Miao
    Arthritis Research & Therapy, 25
  • [27] M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics
    Huang, Yurong
    Xue, Qiuyun
    Chang, Jun
    Wang, Yuting
    Cheng, Chenglong
    Xu, Suowen
    Wang, Xiao
    Miao, Chenggui
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [28] N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential
    Sun, Yuting
    Jin, De
    Zhang, Ziwei
    Ji, Hangyu
    An, Xuedong
    Zhang, Yuehong
    Yang, Cunqing
    Sun, Wenjie
    Zhang, Yuqing
    Duan, Yingying
    Kang, Xiaomin
    Jiang, Linlin
    Zhao, Xuefei
    Lian, Fengmei
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2023, 1866 (04):
  • [29] WTAP-VIRMA counteracts dsDNA binding of the m6A writer METTL3-METTL14 complex and maintains N6-adenosine methylation activity
    Yan, Xuhui
    Liu, Feiqing
    Yan, Junjun
    Hou, Mengjun
    Sun, Min
    Zhang, Delin
    Gong, Zhou
    Dong, Xu
    Tang, Chun
    Yin, Ping
    CELL DISCOVERY, 2023, 9 (01)
  • [30] RNA Modification by m6A Methylation in Cardiovascular Disease
    Chen, Jun
    Wei, Xiang
    Yi, Xin
    Jiang, Ding-Sheng
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021